ArticleMolecules (Basel, Switzerland)2021

Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase.

Kanasap Kaewchim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.